Clinical Trial Update: TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating TSR-042 (dostarlimab) in addition to standard radiation therapy for inoperable endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• TSR-042 (dostarlimab) (dostarlimab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Endometrial Cancer, Cancer of the Endometrium | Phase 1 | Status: ACTIVE_NOT_RECRUITING